ANI Pharmaceuticals reported $328.72M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
AbbVie USD 43.1B 1.46B Sep/2026
ANI Pharmaceuticals USD 328.72M 45.06M Sep/2026
Aurora Cannabis CAD 73.43M 6.5M Jun/2026
Canopy Growth CAD 166.75M 8.31M Jun/2026
Eli Lilly USD 47B 745M Sep/2026
Emergent BioSolutions USD 651.3M 12.7M Dec/2023
Heron Therapeutics USD 89.85M 2.3M Sep/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Nektar Therapeutics USD 57.71M 4.17M Mar/2026
Novartis USD 32.52B 1.15B Sep/2026
Omeros USD 85.5M 2.28M Jun/2025
Perrigo USD 1.02B 34.4M Sep/2026
Sun Pharmaceuticals INR 235.92B 9.7B Sep/2026
Teva Pharmaceutical Industries USD 15.42B 221M Sep/2026